Market Place
Sourcing Support
Arch Therapeutics Presents AC5® at SAWC Fall Meeting
01 Oct 2024 //
GLOBENEWSWIRE
ARCH backs lab instrument company that wants to help demystify how cells talk
11 Jun 2024 //
ENDPTS
Arch To Present AC5® Wound System At SAWC Spring 2024
06 May 2024 //
GLOBENEWSWIRE
Arch Therapeutics Provides Year End Operational Update
09 Nov 2023 //
GLOBENEWSWIRE
Arch Therapeutics to Present AC5® Advanced Wound System
02 Nov 2023 //
GLOBENEWSWIRE
Arch Therapeutics Completes Financing as Bridge to Uplisting
07 Sep 2023 //
GLOBENEWSWIRE
Arch Therapeutics to Present AC5® Advanced Wound System at 2023
25 Apr 2023 //
GLOBENEWSWIRE
Dedicated HCPCS Billing Code for Arch Therapeutics AC5 Advanced Wound System Now In Effect
05 Apr 2023 //
GLOBENEWSWIRE
Arch AC5 Advanced Wound System Receives Dedicated HCPCS Billing Code
09 Mar 2023 //
GLOBENEWSWIRE
Arch Announces Contract Sales Force to Advance Commercialization of AC5
07 Mar 2023 //
GLOBENEWSWIRE
Arch Therapeutics Announces Formation of Medical Advisory Board
18 Jan 2023 //
GLOBENEWSWIRE
Arch Announces Reverse Stock Split in Connection with Application
17 Jan 2023 //
GLOBENEWSWIRE
The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation
05 Dec 2022 //
GLOBENEWSWIRE
Arch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors
11 Oct 2022 //
GLOBENEWSWIRE
Arch Therapeutics begins shipment of AC5 Advanced Wound System
26 Sep 2022 //
PHARMABIZ
Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System
23 Sep 2022 //
GLOBENEWSWIRE
Arch Therapeutics Accepted to Present AC5® Advanced Wound System
20 Sep 2022 //
GLOBENEWSWIRE
Arch Therapeutics Announces Intent to Uplist from OTC to a National Exchange
16 Sep 2022 //
GLOBENEWSWIRE
Arch Therapeutics launches multi-site clinical study for AC5 advanced
08 Sep 2022 //
PHARMABIZ
Arch Therapeutics Launches Multi-Site Clinical Study for AC5®
07 Sep 2022 //
GLOBENEWSWIRE
Arch Therapeutics Submits Application to Centers for Medicare
01 Sep 2022 //
GLOBENEWSWIRE
Arch Therapeutics Raises Approximately $3.5M in Convertible Note Financing
07 Jul 2022 //
GLOBENEWSWIRE
Arch Tx Provides Update on Reimbursement Strategy
22 Jun 2022 //
GLOBENEWSWIRE
Arch Therapeutics Experts Showcase AC5 Self-Assembling Peptide Technology
09 May 2022 //
GLOBENEWSWIRE
Arch Therapeutics AC5 Advanced Wound System Presented at 2022 SAWC
13 Apr 2022 //
GLOBENEWSWIRE
Arch Tx AC5 Advanced Wound System to be Presented at 2022 SAWC Spring
04 Apr 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.